Stay updated with breaking news from Johnc Klock. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sanford C. Bernstein initiated coverage on shares of BioMarin Pharmaceutical (NASDAQ:BMRN – Get Rating) in a research note issued to investors on Tuesday, The Fly reports. The brokerage issued an underperform rating and a $81.00 price target on the biotechnology company’s stock. Other research analysts also recently issued reports about the stock. BMO Capital Markets […]
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) – Equities research analysts at William Blair issued their Q1 2023 earnings estimates for BioMarin Pharmaceutical in a report issued on Tuesday, February 28th. William Blair analyst T. Lugo expects that the biotechnology company will post earnings per share of $0.16 for the quarter. The consensus estimate for […]
BioMarin Pharmaceutical (NASDAQ:BMRN – Get Rating) had its price objective raised by equities research analysts at Credit Suisse Group from $110.00 to $127.00 in a research report issued on Tuesday, The Fly reports. The firm presently has an “outperform” rating on the biotechnology company’s stock. Credit Suisse Group’s target price suggests a potential upside of […]
Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) gapped down before the market opened on Tuesday after Canaccord Genuity Group lowered their price target on the stock from $119.00 to $112.00. The stock had previously closed at $103.24, but opened at $99.30. Canaccord Genuity Group currently has a hold rating on the stock. BioMarin […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.